Efficient oncoretroviral transduction of extended long-term culture-initiating cells and NOD/SCID repopulating cells: Enhanced reconstitution with gene-marked cells through an Ex Vivo expansion approach

Human Gene Therapy

Volumn 13, Issue 9, 2002, Pages 1061-1073

  Björgvinsdóttir, Helga ^a   Bryder, David ^a   Sitnicka, Ewa ^a   Ramsfjell, Veslemøy ^a   de Jong, Ineke ^a   Olsson, Karin ^a   Rusterholz, Corinne ^a   Karlsson, Stefan ^a   Jacobsen, Sten Eirik W ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STEM CELL FACTOR;

ARTICLE; BONE MARROW; CELL DIVISION; CELL POPULATION; CONTROLLED STUDY; GENE TARGETING; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NONHUMAN; NORMAL HUMAN; PROTEIN EXPRESSION; RETROVIRUS; SCID MOUSE; STEM CELL; UMBILICAL CORD BLOOD; XENOGRAFT;

ADP-RIBOSYL CYCLASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; CELL DIVISION; CELL LINE; CULTURE MEDIA; FETAL BLOOD; GENE TRANSFER TECHNIQUES; HEMATOPOIETIC STEM CELLS; HUMANS; KINETICS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; NAD+ NUCLEOSIDASE; RETROVIRIDAE; TIME FACTORS; TRANSDUCTION, GENETIC;

UNIDENTIFIED RETROVIRUS;

EID: 0036293903     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303402753812467     Document Type: Article

References (59)

1. Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells
2. Efficient transduction of human hematopoietic repopulating cells generating stable engraftment of transgene-expressing cells in NOD/SCID mice
3. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture
4. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells
5. Gene transfer to hematopoietic cells
6. Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro
7. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors
8. High marrow seeding efficiency of human lymphomyeloid repopulating cells in irradiated NOD/SCID mice
9. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice
10. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
11. A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells
12. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice
13. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential
14. Engraftment and retroviral marking of CD34+ and CD34+CD38-human hematopoietic progenitors assessed in immune-deficient mice
15. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells
16. Reduction in levels of the cyclin-dependent kinase inhibitor p27 (kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells
17. A defined window for efficient gene marking of severe combined immunodeficient-repopulating cells using a gibbon ape leukemia virus-pseudotyped retroviral vector
18. Assay of human stem cells by repopulation of NOD/SCID mice
19. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice
20. Self-renewal, differentiation or death: Regulation and manipulation of hematopoietic stem cell fate
21. Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: Dissociation of SRC phenotype and function
22. Gene marking and gene therapy directed at primary hematopoietic cells
23. Transforming growth factor beta (TGF-beta), a potent inhibitor of erythropoiesis: Neutralizing TGF-beta antibodies show erythropoietin as a potent stimulator of murine burst-forming unit erythroid colony formation in the absence of a burst-promoting activity
24. Characterization and retroviral transduction of an early human lymphomyeloid precursor assayed in nonswitched long-term culture on murine stroma
25. Retroviral vector-mediated gene transfer into umbilical cord blood CD34brCD38-CD33- cells
26. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture
27. Human hematopoietic cell populations with short term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin null mice
28. Increased stable retroviral gene transfer in early hematopoietic progenitors released from quiescence
29. A functional comparison of CD34+ CD38- cells in cord blood and bone marrow
30. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population
31. Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables
32. Efficient retrovirus-mediated gene transfer to transplantable human bone marrow cells in the absence of fibronectin
33. Treatment of genetic defects in hematopoietic cell function by gene transfer
34. Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein
35. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor
36. Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates
37. Developmental potential and dynamic behavior of hematopoietic stem cells
38. Retrovirus-mediated gene transfer into human CD34+38low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo
39. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability
40. Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice
41. Ex vivo culture of cord blood CD34+ cells expands progenitor cell numbers, preserves engraftment capacity in nonobese diabetic/severe combined immunodeficient mice, and enhances retroviral transduction efficiency
42. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL- 6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts
43. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: Novel responses to Flt3-ligand and thrombopoietin
44. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(1) cord blood cells after ex vivo expansion: Evidence for the amplification and self-renewal of repopulating stem cells
45. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: Distinct and key interactions with the ligands for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha
46. Distinct requirements for optimal growth and in vitro expansion of human CD34(+)CD38(-) bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine in vivo long-term reconstituting stem cells
47. One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus
48. High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions
49. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability
50. Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential
51. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor
52. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: Implications for stem cell frequency assessment
53. Highly efficient transduction of the green fluorescent protein gene in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice
54. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse
55. Progress in the use of gene transfer methods to treat genetic blood diseases
56. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells
57. Abrogation of TGF-beta activity during retroviral transduction improves murine hematopoietic progenitor and repopulating cell gene transfer efficiency
58. Ontogeny-associated changes in the cytokine responses of primitive human haemopoietic cells
59. The human/sheep xenograft model: A large animal model of human hematopoiesis